Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China

Advances in Therapy

Volumn 27, Issue 11, 2010, Pages 814-827

  Palmer, James L ^a   Beaudet, Amélie ^a   White, Jeremy ^b   Plun Favreau, Juliette ^c   Smith Palmer, Jayne ^a  

^a IQVIA   (United States)

^b Novo Nordisk FemCare AG   (Switzerland)

^c NOVO NORDISK A S   (Denmark)

Author keywords

China; Cost effectiveness; Insulin; Modeling; Type 2 diabetes

Indexed keywords

INSULIN ASPART; INSULIN GLARGINE;

ARTICLE; CARDIOVASCULAR RISK; CHINA; COMPLICATION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG RESPONSE; HEALTH CARE COST; LIFE EXPECTANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; QUALITY OF LIFE; RISK REDUCTION; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; RISK;

EID: 78649290679     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0078-6     Document Type: Article

References (45)

1. A. Boutayeb S. Boutayeb 2005 The burden of non communicable diseases in developing countries Int J Equity Health 4 2 10.1186/1475-9276-4-2 15651987 (Pubitemid 40300842)
2. M. Schooling G.M. Leung E.D. Janus S.Y. Ho A.J. Hedley T.H. Lam 2004 Childhood migration and cardiovascular risk Int J Epidemiol. 33 1219 1226 10.1093/ije/dyh221 15567872 (Pubitemid 40124919)
3. W. Zhao J. Chen 2001 Implications from and for food cultures for cardiovascular disease: diet, nutrition and cardiovascular diseases in China Asia Pacific J Clin Nutr. 10 146 152 1:STN:280:DC%2BD3MnmsVKjsw%3D%3D 10.1046/j.1440-6047.2001.00224.x (Pubitemid 33265133)
4. B.M. Popkin 2001 Nutrition in transition: the changing global nutrition challenge Asia Pacific J Clin Nutr. 10 S13 S18
5. J.L. Palmer M. Gibbs H.W. Scheijbeler 2008 Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China Adv Ther. 25 752 774 1:CAS:528:DC%2BD1cXhsV2ksbjM 10.1007/s12325-008-0080-4 18704282
6. X. Xie H. Vondeling 2008 Cost-utility analysis of intensive blood glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing, P.R. China Value Health 11 S23 S32 10.1111/j.1524-4733. 2008.00363.x 18387063 (Pubitemid 351490455)
7. W. Wang C.W. Fu C.Y. Pan 2009 How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 12 923 929 10.1111/j.1524-4733.2009.00561.x 19824187
8. B. Jönsson 2002 Revealing the cost of type II diabetes in Europe Diabetologia 45 S5 S12 10.1007/s00125-002-0858-x 12136405
9. E. Heeley C.S. Anderson Y. Huang 2009 Role of health insurance in averting economic hardship in families after acute stroke in China Stroke 40 2149 2156 10.1161/STROKEAHA.108.540054 19359646
10. Q. Sun M.A. Santoro Q. Meng C. Liu K. Eggleston 2008 Pharmaceutical policy in China Health Affairs 27 1042 1050 10.1377/hlthaff.27.4.1042 18607039
11. The UK Prospective Diabetes Study Group. 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
12. A. Wright A.C. Burden R.B. Paisey C.A. Cull R.R. Holman 2002 Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57) Diabetes Care 25 330 336 1:CAS:528:DC%2BD38Xhtlyks74%3D 10.2337/diacare.25.2.330 11815505 (Pubitemid 41079631)
13. P. Raskin E. Allen P. Hollander 2005 Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs Diabetes Care 28 260 265 1:CAS:528:DC%2BD2MXhsFOmsrc%3D 10.2337/diacare.28.2.260 15677776 (Pubitemid 40170923)
14. K. Strojek W.M. Bebakar D.T. Khutsoane 2009 Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT Curr Med Res Opin. 25 2887 2294 1:CAS:528:DC%2BD1MXhsVCrsL3I 10.1185/03007990903354674 19821654
15. A.J. Palmer S. Roze W.J. Valentine 2004 The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making Curr Med Res Opin. 20 S5 S26 10.1185/ 030079904X1980 15324513 (Pubitemid 39349905)
16. A.J. Palmer S. Roze W.J. Valentine 2004 Validation of the CORE Diabetes Model against epidemiological and clinical studies Curr Med Res Opin. 20 S27 S40 10.1185/030079904X2006 15324514 (Pubitemid 39349906)
17. World Health Organization. WHO Statistical Information System Mortality Database. Available from: URL: http://apps.who.int/whosis/database/mort/table1. cfm. Last accessed December 1, 2009.
18. World Health Organization. Health statistics and health information systems. Global Burden of Disease. Available from: URL: http://www.who.int/ healthinfo/global-burden-disease/en/. Last accessed December 1, 2009.
19. L. Annemans N. Demarteau S. Hu 2008 An Asian regional analysis of the cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy Value Health 11 354 364 10.1111/j.1524-4733.2007.00250.x 17888064 (Pubitemid 351712966)
20. S. Lin 2003 Nephrology in China: a great mission and momentous challenge Kidney Int. 83 S108 S110 10.1046/j.1523-1755.63.s83.22.x
21. P.C. Tong A.P. Kong W.Y. So 2007 Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with type 2 diabetes mellitus Diabet Med. 24 741 746 1:STN:280:DC%2BD2sznvFSgsg%3D%3D 10.1111/j.1464-5491.2007.02145.x 17403120 (Pubitemid 47012127)
22. V.H. Tam E.P. Lam B.C. Chu K.K. Tse L.M. Fung 2009 Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus J Diabetes Complications 23 185 193 10.1016/j.jdiacomp.2008.03.001 18479945
23. I.M. Stratton A.I. Adler H.A. Neil 2000 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study Br Med J. 321 405 412 1:STN:280: DC%2BD3cvisFWnsg%3D%3D 10.1136/bmj.321.7258.405
24. L.F. Zhang J. Yang Z. Hong 2003 Proportion of different subtypes of stroke in China Stroke 34 2091 2096 10.1161/01.STR.0000087149.42294.8C 12907817 (Pubitemid 37099817)
25. World Health Organization. The Tobacco Atlas. Geneva; 2002.
26. World Health Organization. Global Status Report on Alcohol. Geneva; 2004.
27. P.M. Clarke A.M. Gray A. Briggs 2004 A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) Diabetologia 47 1747 1759 1:STN:280:DC%2BD2crnvFWquw%3D%3D 10.1007/s00125-004-1527-z 15517152 (Pubitemid 40022410)
28. M.C. Weinstein B. O'Brien J. Hornberger 2003 Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies Value Health 6 9 17 10.1046/j.1524-4733.2003.00234.x 12535234 (Pubitemid 36228345)
29. National Bureau of Statistics of China. National Annual Statistical Bulletin 2007-2008. Available from: URL: http://www.stats.gov.cn/english/. Accessed December 1, 2009.
30. World Health Organization. Making Choices in Health: WHO guide to cost-effectiveness analysis. Geneva; 2003.
31. P. Clarke A. Gray R. Holman 2002 Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) Med Decis Making 22 340 349 12150599
32. T.O. Tengs A. Wallace 2000 One thousand health-related quality-of-life estimates Med Care 38 583 637 1:STN:280:DC%2BD3czgtVaqtA%3D%3D 10.1097/00005650-200006000-00004 10843310
33. Begg S, Vos T, Barker B, et al. The Burden of Disease and Injury in Australia 2003. Canberra: Australian Institute of Health and Welfare; 2007.
34. A.L. Carrington S.K. Mawdsley M. Morley J. Kincey A.J. Boulton 1996 Psychological status of diabetic people with or without lower limb disability Diabetes Res Clin Pract. 32 19 25 1:STN:280:DyaK28zps1emug%3D%3D 10.1016/0168-8227(96)01198-9 8803478 (Pubitemid 26191382)
35. C.J. Currie C.L. Morgan C.D. Poole P. Sharplin M. Lammert P. McEwan 2006 Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes Curr Med Res Opin. 22 1523 1534 10.1185/030079906X115757 16870077 (Pubitemid 44297431)
36. F. Barzi A. Patel D. Gu 2007 Cardiovascular risk prediction tools for populations in Asia J Epidemiol Community Health 61 115 121 1:STN:280: DC%2BD2s%2FjsFWitQ%3D%3D 10.1136/jech.2005.044842 17234869 (Pubitemid 46174217)
37. X. Yang W.Y. So A.P. Kong 2007 Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry Diabetes Care 30 65 70 10.2337/dc06-1273 17192335 (Pubitemid 46052501)
38. A.H. Briggs D.E. Wonderling C.Z. Mooney 1997 Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation Health Econ. 6 327 340 1:STN:280:DyaK2svjtFWhug%3D%3D 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W 9285227 (Pubitemid 27384638)
39. J.C.N. Chan M.C.Y. Ng A.J.H. Critchley S.C. Lee C.S. Cockram 2001 Diabetes mellitus-a special medical challenge from a Chinese perspective Diabetes Res Clin Pract. 54 S19 S27 10.1016/S0168-8227(01)00305-9 11580965
40. P. Brunetti 2007 The lean patient with type 2 diabetes: characteristics and therapy challenge Int J Clin Pract. 61 3 9
41. R. Huxley W.P. James F. Barzi 2008 Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension Obes Rev. 9 S53 S61 10.1111/j.1467-789X.2007.00439.x (Pubitemid 351643191)
42. A.J. Garber J. Wahlen T. Wahl 2006 Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study) Diabetes Obes Metab. 8 58 66 1:CAS:528: DC%2BD28XitFyjsro%3D 10.1111/j.1463-1326.2005.00563.x 16367883
43. X. Yang W.Y. So A.P. Kong 2008 Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus Am J Cardiol. 101 596 601 10.1016/j.amjcard.2007.10.019 18308005 (Pubitemid 351635559)
44. Y. Wu X. Liu X. Li 2006 Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults Circulation 114 2217 2225 10.1161/CIRCULATIONAHA.105.607499 17088464 (Pubitemid 44789496)
45. J. Liu Y. Hong R.B. D'Agostino 2004 Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study JAMA 291 2591 2599 1:CAS:528:DC%2BD2cXkslWnsro%3D 10.1001/jama.291.21.2591 15173150 (Pubitemid 38702777)